MARKET

FLNA

FLNA

Filana Therapeutics
NASDAQ
1.990
+0.040
+2.05%
After Hours: 2.020 +0.03 +1.51% 18:56 03/13 EDT
OPEN
2.040
PREV CLOSE
1.950
HIGH
2.060
LOW
1.950
VOLUME
580.20K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
1.150
MARKET CAP
96.13M
P/E (TTM)
-0.9055
1D
5D
1M
3M
1Y
5Y
1D
Cassava Sciences FY 2025 net loss widens to USD 91 million as R&D expense falls 62% to USD 26.6 million
Reuters · 3d ago
Cassava Sciences GAAP EPS of -$0.26
Seeking Alpha · 3d ago
Filana Therapeutics sees 1H26 net cash use in operations $14M-$17M
TipRanks · 3d ago
Press Release: Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Dow Jones · 3d ago
*News On Cassava Sciences Inc. (SAVA) Now Under FLNA
Dow Jones · 4d ago
Cassava Sciences Rebrands as Filana Therapeutics, Updates Ticker
TipRanks · 5d ago
Cassava Sciences announces name change to Filana Therapeutics
TipRanks · 5d ago
Cassava Sciences Changes Name To Filana Therapeutics, Ticker To FLNA, Effective March 11
Benzinga · 5d ago
More
About FLNA
Filana Therapeutics, Inc., formerly Cassava Sciences, Inc., is a clinical-stage biotechnology company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, is an early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Webull offers Filana Therapeutics, Inc stock information, including NASDAQ: FLNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FLNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FLNA stock methods without spending real money on the virtual paper trading platform.